{"id":"W2125336138","doi":"10.1016/s0049-3848(10)70147-x","title":"Factor Xa and thrombin as targets for new oral anticoagulants","year":2010,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Fondaparinux; Medicine; Warfarin; Anticoagulant; Discovery and development of direct thrombin inhibitors; Heparin; Drug; Coagulation; Intensive care medicine; Anticoagulant drug; Thrombin; Rivaroxaban; Pharmacology; Factor X; Thrombosis; Surgery; Internal medicine; Atrial fibrillation; Venous thromboembolism","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001979739,0.0003232651,0.001067655,0.0006054031,0.0002130925,0.002215333,0.0003886809,0.00134167,0.00335989],"category_scores_gemma":[0.003885205,0.0001837567,0.000378678,0.000624938,0.0004746538,0.002003394,0.0003837598,0.001515819,0.0004655418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000603307,"about_ca_system_score_gemma":0.0009623904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005586498,"about_ca_topic_score_gemma":0.001376824,"domain_scores_codex":[0.9990751,0.0003765848,0.0001195264,0.00006927124,0.0002723529,0.00008711842],"domain_scores_gemma":[0.9982592,0.0009314941,0.0003306198,0.00005332676,0.0002154223,0.0002099844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01801851,0.001175011,0.059152,0.001586145,0.0005355509,0.001925751,0.0005280865,0.001316551,0.01212454,0.01425786,0.02669913,0.862681],"study_design_scores_gemma":[0.01154792,0.02347892,0.3141717,0.002691938,0.004722156,0.01585718,0.003447257,0.01495523,0.01926895,0.07497944,0.5145724,0.0003069516],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2772958,0.635816,0.001625536,0.05692378,0.002825005,0.00007257306,0.0003105042,0.00005340399,0.02507744],"genre_scores_gemma":[0.7623467,0.2077347,0.003383406,0.007535466,0.01134202,0.0001106078,0.0003323229,0.00002227397,0.007192514],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00335989,"threshold_uncertainty_score":0.01123995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3491276980968377,"score_gpt":0.5174416010417089,"score_spread":0.1683139029448711,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}